Analysis of deaths during the first wave of a new coronavirus infection – COVID-19

Abstract

The aim – study the main causes and factors that led to the death of patients with pneumonia from a new coronavirus infection (COVID-19) in a hospital setting.

Material and methods. Analysis of 84 case histories with fatal outcomes, as well as postmortem examination of 6 deceased patients.

Results and discussion. Comparative analysis of overall mortality rates by nosology among the population for the period 2019–2020 (n=33 537; 36 299) shows that in 2020 the number of patients who died from respiratory diseases increased 2.1 times or 106%, from infectious and parasitic diseases – 1.3 times or 30.8%.

The first case of infection with a new coronavirus infection (COVID-19) among citizens of the Republic of Tajikistan was registered on April 30, 2020, it was then that a quarantine restrictions was announced in the country. The peak of infection in Tajikistan fell in mid-May and the first ten days of June 2020, when from 80 to 210 patients were registered per day.

In Tajikistan, since January 10, 2021, no cases of COVID-19 have been officially registered. As of January 30, 2021, the number of people infected with COVID-19 in the country was 13 308, of which 13 218 (99.3%) people were cured, 90 (0.68%) people died.

The number of cases of pneumonia in the first 10 months of 2020 compared to 2019 increased from 12 802 to 18 504 people, or by 5702, and the number of deaths – from 129 to 291, that is, 2.3 times or 125.6%. At the same time, 10 606 cases of COVID-19 associated with pneumonia were registered in Tajikistan during this period, which amounted to 57.3% of the total number of cases.

An analysis of the history of the deceased showed that in 4.3% of cases the age of the deceased was from 30 to 39 years, in 30.4% – from 40 to 60 years and in 65.3% – over 61 years.

Conclusion. The analysis of deaths among the population of Tajikistan shows that in 2020 there was an increase in the mortality rate, the incidence of seasonal pneumonia and the number of patients with COVID-19 associated with pneumonia.

Keywords:coronavirus infection, COVID-19, pneumonia, seasonal pneumonia, lethality, acute respiratory failure

Funding. There was no financial support.

Conflict of interest. The authors declare no conflicts of interest.

Contribution. Study concept and design – Tursunov R.A., Khojamuradov G.M.; collection and processing of material – Olimov D.A., Tursunov R.A.; statistical processing – Olimov D.A.; writing an article – Tursunov R.A., Olimov D.A.; editing – Khojamuradov G.M.

For citation: Tursunov R.A., Olimov D.A., Khojamuradov G.M. Analysis of deaths during the first wave of a new coronavirus infection – COVID-19 Infektsionnye bolezni: novosti, mneniya, obuchenie [Infectious Diseases: News, Opinions, Training]. 2021; 10 (3): 33–40. DOI: https://doi.org/10.33029/2305-3496-2021-10-3-33-40 (in Russian)

1. Pshenichnaya N.Yu., Veselova E.I., Semenova D.A., Ivanova S.S., Zhuravlev A.S. COVID19 is a new global threat to humanity. Epidemiologiya i infektsionnye bolezni. Aktual’nye voprosy [Epidemiology and Infectious Diseases. Actual Issues]. 2020; 10 (1): 6–13. DOI: https://dx.doi. org/10.18565/epidem.2020.10.1.6-13 (in Russian)

2. Briko N.I., Kagramanyan I.N., Nikiforov V.V., Suranova T.G., Chernyavskaya O.P., Polezhaeva N.A. Pandemic COVID-19. Measures to combat its spread in the Russian Federation. Epidemiologiya i vaktsinoprofilaktika [Epidemiology and Vaccine Prophylaxis]. 2020; 19 (2): 4–12. DOI: https://doi.org/10.31631/2073-3046-2020-19-2-4-12 (in Russian)

3. Rassokhin V.V., Samarina A.V., Belyakov N.A., Trofimova T.N., Lukina O.V., Gavrilov P.V., Grinenko O.A. Epidemiology, clinic, diagnosis, assessment of the severity of the disease COVID-19, taking into account the concomitant pathology. VICH infektsiya i immunosupressii [HIV Infection and Immunosuppression]. 2020; 12 (2): 7–30. DOI: https://doi. org/10.22328/2077-9828-2020-12-2-7-30 (in Russian)

4. Malinnikova E.Yu. New coronavirus infection. Today’s look at the 21st century pandemic. Infektsionnye bolezni: novosti, mneniya, obuchenie [Infectious Diseases: News, Opinions, Training]. 2020; 9 (2): 18–32. (in Russian)

5. Kahathuduwa C.N., Dhanasekara C.S., Chin S.H. Case fatality rate in COVID-19: a systematic review and meta-analysis. MedRxiv. 2020. DOI: https://doi.org/10.1101/2020.04.01.20050476.

6. Spychalski P., Błazynska-Spychalska A., Kobiela J. Estimating case fatality rates of COVID-19. Lancet Infect Dis. 2020; 20 (7): 774–5. DOI: https://doi.org/10.1016/S1473-3099(20)30246-2.

7. Mandal M., Mandal S. Estimating global case fatality rate of coronavirus disease 2019 (COVID-19) pandemic. Int J Clin Microbiol Biochem Technol. 2020; 3: 36–9. DOI: https://doi.org/10.29328/journal. ijcmbt.1001014/

8. Ioannidis J.P.A. The infection fatality rate of COVID-19 inferred from seroprevalence data. medRxiv. 2020. DOI: https://doi.org/10.1101/2020.05.13.20101253.

9. Bisiness Insider. WHO, 2020.

10. Chen L., Liu H.G., Liu W., Liu J., Liu K., Shang J., et al. Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 2020; 43 (3): 203–8. DOI: https://doi. org/10.3760/cma.j.issn.1001-0939.2020.03.013

11. Alizoda S., Tursunov R.A. Monitoring and assessment of the epidemiological situation of coronavirus infection in the Republic of Tajikistan. In: Materials of the International Scientific and Practical Conference on Counteracting the New Coronavirus Infection and Other Infectious Diseases. Saint Petersburg, December 9–10, 2020: 15–7. (in Russian)

12. Tursunov R.A., Ruziev M.M., Saidov Kh.M. Diagnostic markers of COVID-19 among the population of the Republic of Tajikistan. In: Materials of the Republican scientific-practical conference on the topic: «Coronavirus infection in the Republic of Tajikistan: epidemiology, diagnosis and modern treatment options». Dushanbe, December 15, 2020: 212–3. (in Russian)

13. Report of the WHO-China joint mission on coronavirus disease COVID-2019. Epidemiol Vaccin Prev. 2020; 19 (1): 98.

14. WHO. Pneumonia of unknown cause – China. URL: www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/

15. Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323 (11): 1061–9. PMID: 32031570. DOI: https://doi.org/10.1001/jama.2020.1585

16. Huang C., Wang Y., Li X., Ren L., Zhao J., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395: 497–506. DOI: https://doi.org/10.1016/S0140-6736(20)30183-5

17. Semenov A.V., Pshenichnaya N.Yu. Lessons from the COVID-19 epidemic in Italy. Infektsiya i immunitet [Infection and Immunity]. 2020; 10 (3): 410–20. (in Russian)

18. Nikiforov V.V., Suranova T.G., Chernobrovkina T.Ya., Yankovskaya Ya.D., Burova S.V. Novel coronavirus infection (COVID-19): clinical and epidemiological aspects. Arkhiv vnutrenney meditsiny [Archives of Internal Medicine]. 2020; 10 (2): 87–93. DOI: https://doi.org/10.20514/2226-6704-2020-10-2-87-93. (in Russian)

19. Meyerowitz-Katz G., Merone L. A systematic review and metaanalysis of published research data on COVID-19 infection fatality rates. Int J Infect Dis. 2020; 101: 138–148. DOI: https://doi.org/10.1016/j. ijid.2020.09.1464

20. Gold M.S., Sehayek D., Gabrielli S., Zhang X., McCusker C., BenShoshan M. COVID-19 and comorbidities: a systematic review and metaanalysis. Postgrad Med. 2020; 132 (8): 749–55. DOI: https://doi.org/10.1080/00325481.2020.1786964

21. Jain V., Yuan J-M. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. Int J Public Health. 2020; 65: 533–46. DOI: https://doi. org/10.1007/s00038-020-01390-7

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
Aleksandr V. Gorelov
Academician of the Russian Academy of Sciences, MD, Head of Infection Diseases and Epidemiology Department of the Scientific and Educational Institute of Clinical Medicine named after N.A. Semashko ofRussian University of Medicine, Ministry of Health of the Russian Federation, Professor of the Department of Childhood Diseases, Clinical Institute of Children's Health named after N.F. Filatov, Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Deputy Director for Research, Central Research Institute of Epidemiology, Rospotrebnadzor (Moscow, Russian Federation)

Journals of «GEOTAR-Media»